13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001213900-25-110767
Total Value
$1.24B
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 2,278,203 | $154.0M | 12.39% |
| 2 | Verona Pharma PLC | 925050106 | 1,393,432 | $148.7M | 11.97% |
| 3 | Cidara Therapeutics, Inc. | 171757206 | 1,311,425 | $125.6M | 10.11% |
| 4 | Terns Pharmaceuticals Inc | TERN | 6,895,746 | $51.8M | 4.17% |
| 5 | Trevi Therapeutics Inc | TRVI | 5,094,668 | $46.6M | 3.75% |
| 6 | Avadel Pharmaceuticals PLC | G29687103 | 2,684,109 | $41.0M | 3.30% |
| 7 | Cogent Biosciences Inc | COGT | 2,789,137 | $40.1M | 3.22% |
| 8 | Sinovac Biotech Ltd. | SVA | 5,903,000 | $38.2M | 3.07% |
| 9 | Oric Pharmaceuticals Inc | ORIC | 3,126,604 | $37.5M | 3.02% |
| 10 | Geron Corp | GERN | 27,225,292 | $37.3M | 3.00% |
| 11 | Compass Therapeutics Inc | CMPX | 9,545,466 | $33.4M | 2.69% |
| 12 | Dyne Therapeutics Inc | DYN | 2,614,960 | $33.1M | 2.66% |
| 13 | Abivax SA - ADR | AAVXF | 359,305 | $30.5M | 2.45% |
| 14 | Bright Minds Biosciences Inc | DRUG | 501,617 | $30.4M | 2.45% |
| 15 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $28.3M | 2.28% |
| 16 | Zenas Biopharma Inc | ZBIO | 1,183,260 | $26.3M | 2.11% |
| 17 | Verastem Inc | VSTM | 2,644,985 | $23.4M | 1.88% |
| 18 | SAB Biotherapeutics Inc | SABSW | 11,420,000 | $23.0M | 1.85% |
| 19 | Viridian Therapeutics Inc | VRDN | 982,576 | $21.2M | 1.71% |
| 20 | Akero Therapeutics Inc | 00973Y108 | 434,689 | $20.6M | 1.66% |
| 21 | Erasca Inc | ERAS | 9,273,428 | $20.2M | 1.63% |
| 22 | Rezolute Inc | RZLT | 2,112,432 | $19.9M | 1.60% |
| 23 | Aclaris Therapeutics, Inc. | ACRS | 8,888,888 | $16.9M | 1.36% |
| 24 | Corvus Pharmaceuticals Holdings | CRVS | 2,234,566 | $16.5M | 1.33% |
| 25 | Olema Pharmaceuticals Inc | OLMA | 1,505,862 | $14.7M | 1.19% |
| 26 | Dianthus Therapeutics Inc | DNTH | 353,998 | $13.9M | 1.12% |
| 27 | LB Pharmaceuticals Inc | LBRX | 800,000 | $12.6M | 1.02% |
| 28 | CAMP4 Therapeutics Inc | CAMP | 3,921,568 | $11.8M | 0.95% |
| 29 | Astria Therapeutics Inc | 04635X102 | 1,552,685 | $11.3M | 0.91% |
| 30 | Pepgen Inc | PEPG | 2,325,000 | $10.7M | 0.86% |
| 31 | DBV Technologies SA | DBVTF | 1,054,506 | $10.5M | 0.85% |
| 32 | Praxis Precision Medicines | PRAX | 198,895 | $10.5M | 0.85% |
| 33 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $9.7M | 0.78% |
| 34 | Cytomx Therapeutics Inc | CTMX | 2,884,615 | $9.2M | 0.74% |
| 35 | Eupraxia Pharmaceuticals Inc | EPRX | 1,350,000 | $8.0M | 0.64% |
| 36 | Unicycive Therapeutics | UNCY | 1,789,916 | $7.8M | 0.63% |
| 37 | Monopar Therapeutics Inc | MNPR | 90,500 | $7.4M | 0.59% |
| 38 | Tango Therapeutics Inc | TNGX | 776,699 | $6.5M | 0.53% |
| 39 | Delcath Systems, Inc. | DCTH | 569,526 | $6.1M | 0.49% |
| 40 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $5.7M | 0.46% |
| 41 | 89Bio Inc | 282559103 | 376,804 | $5.5M | 0.45% |
| 42 | Instil Bio Inc | TIL | 292,743 | $5.2M | 0.42% |
| 43 | Sera Prognostics Inc | SERA | 1,650,440 | $5.1M | 0.41% |
| 44 | Surrozen Inc | SRZNW | 260,000 | $3.4M | 0.27% |
| 45 | Tenax Therapeutics Inc | TENX | 208,333 | $1.6M | 0.13% |
| 46 | Bolt Therapeutics Inc | BOLT | 176,064 | $936,660 | 0.08% |
| 47 | Precision Biosciences Inc | DTIL | 4,675 | $25,806 | 0.00% |